BioCatalystWatch
TPSTWorkspace / TPST / OverviewCompany library
Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc.

Tempest Therapeutics, Inc. (TPST)

Website

Price
Market cap
Next catalystU.S. registrational study initiation in Q4 2026, subject to regulatory clearancetpst-2003 · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

TPST-2003

CD19 × BCMA

PreINDP1P2P3FilingApproved
Upcoming / outlook

TPST-2003

CD19 × BCMA

PreINDP1P2P3FilingApproved
Upcoming / outlook

TPST-4003

CD7 × CD19 × BCMA

Upcoming / outlook

TPST-4003

CD7 × CD19 × BCMA

Upcoming / outlook

  • Timing and evidence

TPST-4903

CD7 (vector delivery) × BCMA × GPRC5D

PreINDP1P2P3FilingApproved
Upcoming / outlook

TPST-3003

CD19 × BCMA

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

TPST-4003

CD7 × CD19 × BCMA

Upcoming / outlook

  • Timing and evidence

TPST-2003

CD19 × BCMA

PreINDP1P2P3FilingApproved
Upcoming / outlook

TPST-2003

CD19 × BCMA

PreINDP1P2P3FilingApproved
Upcoming / outlook

TPST-4003

CD7 × CD19 × BCMA

Upcoming / outlook

TPST-4903

CD7 (vector delivery) × BCMA × GPRC5D

PreINDP1P2P3FilingApproved
Upcoming / outlook

TPST-3003

CD19 × BCMA

PreINDP1P2P3FilingApproved

Other pipelines

TPST-3206

CD70

TPST-2003

CD19 × BCMA

PreINDP1P2P3FilingApproved
TREX1 Inhibitor

TREX1

PreINDP1P2P3FilingApproved
TPST-1495

EP2 × EP4

PreINDP1P2P3FilingApproved

Partner / License out

TPST-3206

CD70

History / paused

PPARα

PreINDP1P2P3FilingApproved

PPARα

PreINDP1P2FilingApproved
TPST-2003

CD19 × BCMA

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

TPST PR & News

PR & News

TPST SEC archive